PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University of Ottawa Heart Institute, Division of Cardiology, Department of Medicine, University of Ottawa, H3214, 40 Ruskin Street, Ottawa, ON, K1Y 4W7, Canada.\', \'Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, K1H8M5, Canada.\', \'Ottawa Hospital Research Institute, Division of Regenerative Medicine, Department of Medicine, University of Ottawa, Ottawa, K1H8L6, Canada.\', \'University of Ottawa Heart Institute, Division of Cardiology, Department of Medicine, University of Ottawa, H3214, 40 Ruskin Street, Ottawa, ON, K1Y 4W7, Canada. ddavis@ottawaheart.ca.\', \'Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, K1H8M5, Canada. ddavis@ottawaheart.ca.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13287-021-02699-7
?:hasPublicationType
?:journal
  • Stem cell research & therapy
is ?:pmid of
?:pmid
?:pmid
  • 35033181
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all